background 2

Take the 2022 Member Survey

As part of a process to revise the IASLC's strategic plan within the next six months, we invite all members to take the IASLC Member Survey on member needs & benefits in the post-COVID world. The survey is available in English, Spanish, French, Korean, Japanese, and Chinese.
Press releases_social cell

Access the WCLC 2022 Press Briefings

Watch the Press Briefings from the IASLC World Conference on Lung Cancer 2022 in Vienna, Austria.
Covers of JTO CRR and JPO

JTO CRR Seeks New Editor-in-Chief

The IASLC invites applications for the Editor-in-Chief for JTO Clinical and Research Reports. Through a global search, JTO CRR seeks to appoint the successor for a 5-year term, anticipated to begin 11/22.
Take the 2022 Member Survey
Access the WCLC 2022 Press Briefings
JTO CRR Seeks New Editor-in-Chief


The International Association for the Study of Lung Cancer

The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. From provision of educational events around the world and virtually to research projects and publications that advance the science of lung cancer, the IASLC's members—consisting of medical, surgical, and radiation oncologists, as well as other thoracic oncology specialists such as nurses, basic scientists, pathologists, radiologists, pulmonologists, statisticians, patient research advocates, patients, and their caregivers—are raising the bar for care of patients with lung cancer.

Explore More

In Focus

Air Pollution and Lung Cancer - The IASLC Position Statement

Lung cancer is a complicated disease with many causes. Among them are tobacco smoke, radon, and asbestos. However, one largely overlooked cause is the relationship between air pollution and lung cancer.


New Translations of the IASLC IHC Atlas are available! From IHC biochemistry basics to identifying biomarkers, this text provides a comprehensive view of diagnostic IHC in a reader-friendly format.

Language Guide page 1

IASLC Language Guide

In line with the IASLC Equity Statement and in step with the ASCO Language of Respect, we are proud to announce the release of the IASLC Language Guide. The guide was established to instill best practices with commonly used phrases related to patient care. The IASLC will be folding the language found in the guide into all aspects of thoracic oncology education, from abstracts to faculty guidelines to podium presentations. 

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

Our Impact

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.

See More

Our Work

The IASLC Staging Project

The IASLC Staging Project is a global effort to study and improve the current staging system for lung cancer, mesothelioma, thymic and esophageal cancer.

Lung Ambition Alliance

The IASLC has formed an alliance with three other founding organizations to allow scientists, specialists, advocates, and patients to break the barriers limiting progress and double 5-year survival rates of lung cancer by 2025.

In Numbers

8,000+ members from over 100 countries, all united by a single goal: to conquer thoracic cancers worldwide.
Years Experience
Number of Research Awards Funded
JTO Impact Factor

Upcoming Meetings & Webinars

Endorsed Event
Oct 29 - Oct 29 2022
October 29, 2022 7 am - 5 pm EST
CME Accredited
JTO-CRR_Hero-0820 - Cropped.jpg

Journal of Thoracic Oncology & JTO Clinical and Research Reports

Lung and thoracic specialists count on the IASLC’s journals to provide perspective on innovation in prevention, detention, diagnosis and cutting-edge treatments. As a leading medical journal, JTO focuses on lung and thoracic cancers and is dedicated to presenting original research reviews and opinions from a wide range of disciplines within the medical community. JTO CRR, the official open access journal of the IASLC, complements the JTO by offering authors a gold open access publication option.